Loading market dashboard
Mirati Therapeutics, Inc.
MRTXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Mirati Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2025 | $316.48M | $206.04M - $513.05M | -$316.48M | -$8.371 | 13 |
| Dec 2024 | $180.71M | $104.00M - $295.30M | -$180.71M | -$10.252 | 15 |
| Dec 2023 | $65.83M | $53.71M - $97.40M | -$672.81M | -$11.81 | 14 |
| Dec 2022 | $27.22M | $17.72M - $44.13M | -$618.11M | -$12.817 | 7 |
| Dec 2021 | $21.45M | $13.96M - $34.77M | -$458.81M | -$10.42 | 7 |
| Dec 2020 | $15.96M | $10.39M - $25.88M | -$357.59M | -$8.07 | 7 |
| Dec 2019 | $2.89M | $1.88M - $4.68M | -$176.72M | -$4.94 | 9 |
| Dec 2018 | $29.19M | $19.01M - $47.33M | $21.58M | -$99,713,138.00 | 7 |